Grading of Chromophobe Renal Cell Carcinoma: Do We Need It?
2020-01-01 Lopez-Beltran, A.; Montironi, R.; Cimadamore, A.; Cheng, L.
Long Non-coding RNAs in prostate cancer with emphasis on second chromosome locus associated with prostate-1 expression
2017-01-01 Cimadamore, Alessia; Gasparrini, Silvia; Mazzucchelli, Roberta; Doria, Andrea; Cheng, Liang; Lopez-Beltran, Antonio; Santoni, Matteo; Scarpelli, Marina; Montironi, Rodolfo
Biological issues with cabozantinib in bone metastatic renal cell carcinoma and castration-resistant prostate cancer
2018-01-01 Di Nunno, Vincenzo; Cimadamore, Alessia; Santoni, Matteo; Scarpelli, Marina; Fiorentino, Michelangelo; Ciccarese, Chiara; Iacovelli, Roberto; Cheng, Liang; Lopez-Beltran, Antonio; Massari, Francesco; Montironi, Rodolfo
From undergraduate medical school student to visible pathologist
2020-01-01 Montironi, R.; Cimadamore, A.; Scarpelli, M.
Exciting experiences in the 'Rocky road to digital diagnostics'
2020-01-01 Montironi, R.; Cimadamore, A.; Lopez-Beltran, A.; Cheng, L.; Scarpelli, M.
Correlation between high pd-l1 and emt/invasive genes expression and reduced recurrence-free survival in blood-circulating tumor cells from patients with non-muscle-invasive bladder cancer
2021-01-01 Morelli, M. B.; Amantini, C.; de Vermandois, J. A. R.; Gubbiotti, M.; Giannantoni, A.; Mearini, E.; Maggi, F.; Nabissi, M.; Marinelli, O.; Santoni, M.; Cimadamore, A.; Montironi, R.; Santoni, G.
p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading
2016-01-01 Guerra, E.; Cimadamore, A.; Simeone, P.; Vacca, G.; Lattanzio, R.; Botti, G.; Gatta, V.; D'Aurora, M.; Simionati, B.; Piantelli, M.; Alberti, S.
The Wide Spectrum of Oncocytic Changes and Tumors in the Kidney: Splitting and Lumping
2021-01-01 Cimadamore, A.; Lopez-Beltran, A.; Scarpelli, M.; Cheng, L.; Montironi, R.
Spectrum of incipient (or precursor) lesions in the mucosa of the seminal vesicles
2021-01-01 Cimadamore, A.; Cheng, L.; Lopez-Beltran, A.; Scarpelli, M.; Montironi, R.
Current application of the enhanced recovery after surgery protocol for patients undergoing radical cystectomy: lessons learned from European excellence centers
2021-01-01 Albisinni, S.; Moschini, M.; Di Trapani, E.; Soria, F.; Mari, A.; Aziz, A.; Teoh, J.; Laukhtina, E.; Mori, K.; D'Andrea, D.; Carrion, D. M.; Krajewski, W.; Abufaraj, M.; Cimadamore, A.; Tan, W. S.; Flippot, R.; Khalifa, J.; Gonsette, K.; Pradere, B.
Targeted therapy for solid tumors and risk of hypertension: a meta-analysis of 68077 patients from 93 phase III studies
2019-01-01 Santoni, M.; Conti, A.; Massari, F.; Di Nunno, V.; Faloppi, L.; Galizia, E.; Morbiducci, J.; Piva, F.; Buti, S.; Iacovelli, R.; Ferretti, B.; Cimadamore, A.; Scarpelli, M.; Lopez-Beltran, A.; Cheng, L.; Battelli, N.; Montironi, R.
Variants and new entities of bladder cancer
2019-01-01 Lopez-Beltran, A.; Henriques, V.; Montironi, R.; Cimadamore, A.; Raspollini, M. R.; Cheng, L.
Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications
2020-01-01 Aurilio, Gaetano; Cimadamore, Alessia; Mazzucchelli, Roberta; Lopez-Beltran, Antonio; Verri, Elena; Scarpelli, Marina; Massari, Francesco; Cheng, Liang; Santoni, Matteo; Montironi, Rodolfo
Digital versus light microscopy assessment of extraprostatic extension in radical prostatectomy samples
2019-01-01 Volavsek, M.; Henriques, V.; Blanca, A.; Montironi, R.; Cheng, L.; Raspollini, M. R.; Cimadamore, A.; Vau, N.; Pierconti, F.; Lopez-Beltran, A.
Designing novel immunocombinations in metastatic renal cell carcinoma
2020-01-01 Santoni, M.; Massari, F.; Aurilio, G.; Mollica, V.; Cimadamore, A.; Lopez-Beltran, A.; Cheng, L.; Battelli, N.; Nole, F.; Montironi, R.
New prostate cancer targets for diagnosis, imaging, and therapy: Focus on prostate-specific membrane antigen
2018-01-01 Cimadamore, A.; Cheng, M.; Santoni, M.; Lopez-Beltran, A.; Battelli, N.; Massari, F.; Galosi, A. B.; Scarpelli, M.; Montironi, R.
Narrative review: Update on immunotherapy and pathological features in patients with bladder cancer
2021-01-01 Aurilio, G.; Cimadamore, A.; Lopez-Beltran, A.; Scarpelli, M.; Massari, F.; Verri, E.; Cheng, L.; Santoni, M.; Montironi, R.
PD1 and PD-L1 Inhibitors for the Treatment of Kidney Cancer: the Role of PD-L1 Assay
2020-01-01 Cimadamore, Alessia; Massari, Francesco; Santoni, Matteo; Lopez-Beltran, Antonio; Cheng, Liang; Scarpelli, Marina; Montironi, Rodolfo; Moch, Holger
Re: Timothy D. Jones, Liang Cheng. Histologic Grading of Bladder Tumors: Using Both the 1973 and 2004/2016 World Health Organization Systems in Combination Provides Valuable Information for Establishing Prognostic Risk Groups. Eur Urol 2021;79:489–91
2021-01-01 Cimadamore, A.; Lopez-Beltran, A.; Scarpelli, M.; Montironi, R.
Key role of obesity in genitourinary tumors with emphasis on urothelial and prostate cancers
2019-01-01 Santoni, M.; Cimadamore, A.; Massari, F.; Piva, F.; Aurilio, G.; Martignetti, A.; Scarpelli, M.; Di Nunno, V.; Gatto, L.; Battelli, N.; Cheng, L.; Lopez-Beltran, A.; Montironi, R.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Grading of Chromophobe Renal Cell Carcinoma: Do We Need It? | 1-gen-2020 | Lopez-Beltran, A.; Montironi, R.; Cimadamore, A.; Cheng, L. | |
| Long Non-coding RNAs in prostate cancer with emphasis on second chromosome locus associated with prostate-1 expression | 1-gen-2017 | Cimadamore, Alessia; Gasparrini, Silvia; Mazzucchelli, Roberta; Doria, Andrea; Cheng, Liang; Lopez-Beltran, Antonio; Santoni, Matteo; Scarpelli, Marina; Montironi, Rodolfo | |
| Biological issues with cabozantinib in bone metastatic renal cell carcinoma and castration-resistant prostate cancer | 1-gen-2018 | Di Nunno, Vincenzo; Cimadamore, Alessia; Santoni, Matteo; Scarpelli, Marina; Fiorentino, Michelangelo; Ciccarese, Chiara; Iacovelli, Roberto; Cheng, Liang; Lopez-Beltran, Antonio; Massari, Francesco; Montironi, Rodolfo | |
| From undergraduate medical school student to visible pathologist | 1-gen-2020 | Montironi, R.; Cimadamore, A.; Scarpelli, M. | |
| Exciting experiences in the 'Rocky road to digital diagnostics' | 1-gen-2020 | Montironi, R.; Cimadamore, A.; Lopez-Beltran, A.; Cheng, L.; Scarpelli, M. | |
| Correlation between high pd-l1 and emt/invasive genes expression and reduced recurrence-free survival in blood-circulating tumor cells from patients with non-muscle-invasive bladder cancer | 1-gen-2021 | Morelli, M. B.; Amantini, C.; de Vermandois, J. A. R.; Gubbiotti, M.; Giannantoni, A.; Mearini, E.; Maggi, F.; Nabissi, M.; Marinelli, O.; Santoni, M.; Cimadamore, A.; Montironi, R.; Santoni, G. | |
| p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading | 1-gen-2016 | Guerra, E.; Cimadamore, A.; Simeone, P.; Vacca, G.; Lattanzio, R.; Botti, G.; Gatta, V.; D'Aurora, M.; Simionati, B.; Piantelli, M.; Alberti, S. | |
| The Wide Spectrum of Oncocytic Changes and Tumors in the Kidney: Splitting and Lumping | 1-gen-2021 | Cimadamore, A.; Lopez-Beltran, A.; Scarpelli, M.; Cheng, L.; Montironi, R. | |
| Spectrum of incipient (or precursor) lesions in the mucosa of the seminal vesicles | 1-gen-2021 | Cimadamore, A.; Cheng, L.; Lopez-Beltran, A.; Scarpelli, M.; Montironi, R. | |
| Current application of the enhanced recovery after surgery protocol for patients undergoing radical cystectomy: lessons learned from European excellence centers | 1-gen-2021 | Albisinni, S.; Moschini, M.; Di Trapani, E.; Soria, F.; Mari, A.; Aziz, A.; Teoh, J.; Laukhtina, E.; Mori, K.; D'Andrea, D.; Carrion, D. M.; Krajewski, W.; Abufaraj, M.; Cimadamore, A.; Tan, W. S.; Flippot, R.; Khalifa, J.; Gonsette, K.; Pradere, B. | |
| Targeted therapy for solid tumors and risk of hypertension: a meta-analysis of 68077 patients from 93 phase III studies | 1-gen-2019 | Santoni, M.; Conti, A.; Massari, F.; Di Nunno, V.; Faloppi, L.; Galizia, E.; Morbiducci, J.; Piva, F.; Buti, S.; Iacovelli, R.; Ferretti, B.; Cimadamore, A.; Scarpelli, M.; Lopez-Beltran, A.; Cheng, L.; Battelli, N.; Montironi, R. | |
| Variants and new entities of bladder cancer | 1-gen-2019 | Lopez-Beltran, A.; Henriques, V.; Montironi, R.; Cimadamore, A.; Raspollini, M. R.; Cheng, L. | |
| Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications | 1-gen-2020 | Aurilio, Gaetano; Cimadamore, Alessia; Mazzucchelli, Roberta; Lopez-Beltran, Antonio; Verri, Elena; Scarpelli, Marina; Massari, Francesco; Cheng, Liang; Santoni, Matteo; Montironi, Rodolfo | |
| Digital versus light microscopy assessment of extraprostatic extension in radical prostatectomy samples | 1-gen-2019 | Volavsek, M.; Henriques, V.; Blanca, A.; Montironi, R.; Cheng, L.; Raspollini, M. R.; Cimadamore, A.; Vau, N.; Pierconti, F.; Lopez-Beltran, A. | |
| Designing novel immunocombinations in metastatic renal cell carcinoma | 1-gen-2020 | Santoni, M.; Massari, F.; Aurilio, G.; Mollica, V.; Cimadamore, A.; Lopez-Beltran, A.; Cheng, L.; Battelli, N.; Nole, F.; Montironi, R. | |
| New prostate cancer targets for diagnosis, imaging, and therapy: Focus on prostate-specific membrane antigen | 1-gen-2018 | Cimadamore, A.; Cheng, M.; Santoni, M.; Lopez-Beltran, A.; Battelli, N.; Massari, F.; Galosi, A. B.; Scarpelli, M.; Montironi, R. | |
| Narrative review: Update on immunotherapy and pathological features in patients with bladder cancer | 1-gen-2021 | Aurilio, G.; Cimadamore, A.; Lopez-Beltran, A.; Scarpelli, M.; Massari, F.; Verri, E.; Cheng, L.; Santoni, M.; Montironi, R. | |
| PD1 and PD-L1 Inhibitors for the Treatment of Kidney Cancer: the Role of PD-L1 Assay | 1-gen-2020 | Cimadamore, Alessia; Massari, Francesco; Santoni, Matteo; Lopez-Beltran, Antonio; Cheng, Liang; Scarpelli, Marina; Montironi, Rodolfo; Moch, Holger | |
| Re: Timothy D. Jones, Liang Cheng. Histologic Grading of Bladder Tumors: Using Both the 1973 and 2004/2016 World Health Organization Systems in Combination Provides Valuable Information for Establishing Prognostic Risk Groups. Eur Urol 2021;79:489–91 | 1-gen-2021 | Cimadamore, A.; Lopez-Beltran, A.; Scarpelli, M.; Montironi, R. | |
| Key role of obesity in genitourinary tumors with emphasis on urothelial and prostate cancers | 1-gen-2019 | Santoni, M.; Cimadamore, A.; Massari, F.; Piva, F.; Aurilio, G.; Martignetti, A.; Scarpelli, M.; Di Nunno, V.; Gatto, L.; Battelli, N.; Cheng, L.; Lopez-Beltran, A.; Montironi, R. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista47360
- 2 Contributo in Volume1
- 3 Libro1
Data di pubblicazione
- In corso di stampa37
- 2020 - 202713529
- 2010 - 201915290
- 2000 - 200910528
- 1990 - 19995844
- 1980 - 19891783
- 1970 - 1979315
- 1960 - 196935
Editore
- Elsevier BV:PO Box 211, 1000 AE A...288
- American Institute of Physics:2 H...269
- Germany: Springer Verlag Germany101
- Elsevier Science Limited:Oxford F...71
- Elsevier Science Incorporated / N...60
- Springer Verlag Germany:Tiergarte...57
- Taylor & Francis Limited:Rankine ...56
- Edizioni Minerva Medica:Corso Bra...52
- S Karger AG:Allschwilerstrasse 10...48
- Annals Publishing Company:4507 La...47
Rivista
- PHYSICAL REVIEW LETTERS520
- PHYSICS LETTERS. SECTION B491
- THE EUROPEAN PHYSICAL JOURNAL. C,...451
- JOURNAL OF HIGH ENERGY PHYSICS351
- PHYSICAL REVIEW D, PARTICLES, FIE...305
- NUCLEAR INSTRUMENTS & METHODS IN ...202
- PHYSICAL REVIEW D157
- THE ASTROPHYSICAL JOURNAL156
- PLOS ONE149
- SCIENTIFIC REPORTS133
Serie
- REGIONAL DOSSIERS SERIES1
Keyword
- Humans1080
- Female609
- Male544
- Middle Aged356
- Italy330
- Adult316
- COVID-19313
- Medicine (all)282
- Aged281
- Biochemistry192
Lingua
- eng30123
- ita9631
- fre359
- spa205
- ger192
- rus48
- fur28
- und27
- lat25
- pol25
Accesso al fulltext
- no fulltext32298
- open8479
- reserved6158
- partially open395
- restricted18
- embargoed10
- mixed3